{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-217296","form_type":"8-K","ticker":"RLAY","cik":"0001812364","company_name":"Relay Therapeutics, Inc.","filed_at":"2024-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.617816+00:00","generated_at":"2026-05-31T05:28:42.056915+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Relay Therapeutics prices $200M public offering of common stock at $7.00/share","bullets":["Public offering of 28.57M shares at $7.00/share; gross proceeds ~$200M.","Net proceeds estimated at ~$189.5M after underwriting discounts and expenses.","Underwriters granted 30-day option to purchase up to an additional 4.29M shares.","Offering expected to close on September 12, 2024; lead managers include Goldman Sachs, TD Cowen, Stifel, BofA Securities.","All shares sold by the company; proceeds will support clinical-stage precision medicine programs."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-217296","json":"https://secwatch.observer/filing/0001193125-24-217296.json","markdown":"https://secwatch.observer/filing/0001193125-24-217296.md","text":"https://secwatch.observer/filing/0001193125-24-217296.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812364/000119312524217296/0001193125-24-217296-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812364/000119312524217296/d892276d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:28:42.056915+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}